Abstract OT1-01-02: A Multicenter Phase II Trial to Evaluate the Efficacy and Safety of Pembrolizumab and Gemcitabine in Patients with HER2-negative Advanced Breast Cancer: GEICAM/2015-04 PANGEA-Breast
Cancer Research（2018）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined